Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primary fungal prophylaxis with liposomal amphotericin B in high‑risk adult orthotopic liver transplant recipients
2007-001924-11Phase 3Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jun 2007
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of liposomal amphotericin b in mycoses, sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Safety of weekly liposomal amphotericin B. Started Jun 2007; status: completed.
02
Drugs
liposomal amphotericin b
03
Conditions
mycoses
Beyond the preview
Go deeper on 2007-001924-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001924-11.